GYKI-52895

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGYKI-52895
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolyamine uptake inhibitors
TargetsUpdating
Therapy Area/IndicationsDepressive Disorder, MajorParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A